1. Home
  2. GBIO vs ARBE Comparison

GBIO vs ARBE Comparison

Compare GBIO & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • ARBE
  • Stock Information
  • Founded
  • GBIO 2016
  • ARBE 2015
  • Country
  • GBIO United States
  • ARBE Israel
  • Employees
  • GBIO N/A
  • ARBE N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • ARBE EDP Services
  • Sector
  • GBIO Health Care
  • ARBE Technology
  • Exchange
  • GBIO Nasdaq
  • ARBE Nasdaq
  • Market Cap
  • GBIO 64.8M
  • ARBE 161.8M
  • IPO Year
  • GBIO 2020
  • ARBE N/A
  • Fundamental
  • Price
  • GBIO $0.88
  • ARBE $3.00
  • Analyst Decision
  • GBIO Strong Buy
  • ARBE Strong Buy
  • Analyst Count
  • GBIO 2
  • ARBE 2
  • Target Price
  • GBIO $6.50
  • ARBE $3.00
  • AVG Volume (30 Days)
  • GBIO 581.0K
  • ARBE 16.7M
  • Earning Date
  • GBIO 03-05-2025
  • ARBE 03-06-2025
  • Dividend Yield
  • GBIO N/A
  • ARBE N/A
  • EPS Growth
  • GBIO N/A
  • ARBE N/A
  • EPS
  • GBIO N/A
  • ARBE N/A
  • Revenue
  • GBIO $18,582,000.00
  • ARBE $1,016,000.00
  • Revenue This Year
  • GBIO $212.74
  • ARBE $1.56
  • Revenue Next Year
  • GBIO N/A
  • ARBE $395.31
  • P/E Ratio
  • GBIO N/A
  • ARBE N/A
  • Revenue Growth
  • GBIO 514.08
  • ARBE N/A
  • 52 Week Low
  • GBIO $0.75
  • ARBE $1.40
  • 52 Week High
  • GBIO $4.65
  • ARBE $5.09
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 28.66
  • ARBE 58.15
  • Support Level
  • GBIO $0.85
  • ARBE $2.67
  • Resistance Level
  • GBIO $1.01
  • ARBE $3.99
  • Average True Range (ATR)
  • GBIO 0.12
  • ARBE 0.61
  • MACD
  • GBIO 0.00
  • ARBE 0.10
  • Stochastic Oscillator
  • GBIO 7.50
  • ARBE 41.78

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.

Share on Social Networks: